A study involving somatic cell LDLR gene correction via CRISPR was conducted with the aim of determining the efficiency of CRISPR/Cas9-mediated LDLR gene editing delivered by AAV in preventing FH and atherosclerosis in the LDLR E208X murine model [46]. Here, LDLR is linked to familial hyperaldosteronism.